Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Quinolinic acid

Quinolinic acid, an endogenous metabolite of tryptophan, is a N-methyl-D-aspartate receptor (NMDA receptor) agonist. Quinolinic acid increases glutamate efflux, induces the generation of ROS, activates nitric oxide synthase, produces excessive NO, leading to calcium ion influx and neuronal apoptosis[1][2][3][4][5][6][7][8].

Product Specifications

CAS Number

89-00-9

UNSPSC

12352005

Hazard Statement

H319, H335

Target

Apoptosis; Endogenous Metabolite; iGluR; NO Synthase; Reactive Oxygen Species (ROS)

Type

Natural Products

Related Pathways

Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Quinolinic_acid.html

Purity

99.88

Solubility

DMSO : 33.33 mg/mL (ultrasonic) |H2O : 3.33 mg/mL (ultrasonic)

Smiles

O=C(C1=NC=CC=C1C(O)=O)O

Molecular Formula

C7H5NO4

Molecular Weight

167.12

Precautions

H319, H335

References & Citations

[1]Heyes MP, et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 1992 Oct;115 (Pt 5) :1249-73.|[2]Jang S, et al. Neuroprotective effects of (-) -epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition. Brain Res. 2010 Feb 8;1313:25-33.|[3]Sugisawa E, et al. Nociceptor-derived Reg3γ prevents endotoxic death by targeting kynurenine pathway in microglia. Cell Rep. 2022 Mar 8;38 (10) :110462.|[4]Lisak RP, et al. Melanocortin receptor agonist ACTH 1-39 protects rat forebrain neurons from apoptotic, excitotoxic and inflammation-related damage. Exp Neurol. 2015 Nov;273:161-7.|[5]Lapin IP. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm. 1978;42 (1) :37-43.|[6]Goel F, et al. Protective effects of diacerein against quinolinic acid-induced Huntington's disease-like symptoms in adult zebrafish by targeting GSK-3β signalling. Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug;398 (8) :10799-10821.|[7]Bains M, et al. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington's disease by targeting IKK-NF-κB pathway. Eur J Pharmacol. 2022 Nov 5;934:175316.|[8]Martínez-Gopar PE, et al. Mast cells and histamine are involved in the neuronal damage observed in a quinolinic acid-induced model of Huntington's disease. J Neurochem. 2022 Jan;160 (2) :256-270.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Natural Products

Clinical Information

No Development Reported

Isoform

Human Endogenous Metabolite; Microbial Metabolite; NMDA Receptor

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Mouse Cfap161 activation kit by CRISPRa
GA210260 1 Kit

Mouse Cfap161 activation kit by CRISPRa

Sign In for Pricing
View Details
Human IgM, AlpHcAbs® Goat
HA710302 100 µg

Human IgM, AlpHcAbs® Goat

Sign In for Pricing
View Details
PTDSS1 (NM_001290225) Human Tagged ORF Clone
RG237460 10 µg

PTDSS1 (NM_001290225) Human Tagged ORF Clone

Sign In for Pricing
View Details
TP53BP2 (NM_001031685) Human Over-expression Lysate
LC421900 20 µg

TP53BP2 (NM_001031685) Human Over-expression Lysate

Sign In for Pricing
View Details
Recombinant Fibronectin Antibody
RC-15286-01 50 μL

Recombinant Fibronectin Antibody

Sign In for Pricing
View Details
Recombinant Fibronectin Antibody
RC-15286-02 100 µL

Recombinant Fibronectin Antibody

Sign In for Pricing
View Details